Hans-Christoph Diener

Scientific Advisor at Achelios Therapeutics

Dr. Diener received his medical degree and doctorate at the Albrecht-Ludwigs-Universität in Freiburg and continued his training there in the Departments of Neurology, Psychiatry, Internal Medicine, and Surgery. Prior to joining the University of Essen, he was an Associate Professor of Neurology at the Department of Neurology at the University of Tübingen. He was also a visiting Professor at the Neurological Sciences Institute in Portland, Oregon in 1984 and 1985 and at the University of New South Wales in Sydney in 1987 and 1988.

Dr. Diener’s special research interests focus on stroke, headache, and cerebellar physiology. He has set up the first acute stroke unit in Germany in 1995. He was and is the principal investigator of major trials in the acute therapy and prevention of stroke (ESPS2, MATCH, PRoFESS, SWIFT-PRIME, RESPECTUS-ESUS) and participated in the recent trials on NOACs in stroke prevention in atrial fibrillation. Dr. Diener is responsible for several multi-center stroke registries.

Prof. Diener has authored or co-authored 858 articles in peer-reviewed journals (179 as first author, 19 in the NEJM), 310 invited reviews, and 332 book chapters, and served as the editor or author of 77 books. His h index is 99. He is the editor of Aktuelle Neurologie, Stroke News, Kopfschmerz News, and Arzneimitteltherapie, deputy editor of Cephalalgia and serves on the editorial boards of Lancet Neurology, Cerebrovascular Diseases, Future Neurology, The International Journal of Clinical Practice, European Neurology, Reviews in Contemporary Pharmacotherapy and Journal of Clinical Investigation.

Timeline

  • Scientific Advisor

    Current role